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abnormal relaxation of the lower esophageal sphincter.
Early disease without marked esophageal dilatation can
be treated by reducing lower esophageal sphincter pres-
sure by either pneumatic dilation or surgical myotomy. In
the absence of therapy, or if therapy is inadequate or com-
plicated by acid reflux, there is progressive dilatation and
eventually marked tortuosity of the esophagus, resulting
in the condition known as end-stage achalasia. The only
solution for end-stage esophageal failure is resection of
the obstructed, dilated sigmoid esophagus. Colon interpo-
sition traditionally has been used to restore gastrointesti-
nal continuity for benign disease. However, the successful
use of the stomach for gastrointestinal reconstruction in
malignant esophageal tumors has led to its consideration
for benign end-stage esophageal diseases.
The purpose of this study was to evaluate a protocol
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Purpose: Achalasia is a degenerative esophageal disorder that may result
in esophageal failure necessitating resection for restoration of gastroin-
testinal function. This study evaluates a protocol of esophageal resection
and gastric reconstruction for end-stage achalasia. Methods: Hospital
records, radiographic studies, and resection specimens of patients
undergoing esophagectomy and gastric reconstruction were reviewed.
Patient outcome was defined by an evaluation of symptoms (early sati-
ety, dysphagia, regurgitation, and reflux), dietary restrictions, and abil-
ity to maintain or gain weight. Preoperative, operative, and postopera-
tive variables and pathologic features in the resection specimens were
analyzed to determine predictors of outcome. Results: In a 10-year peri-
od, 32 patients underwent esophagectomy with gastric reconstruction
for achalasia; 30 (94%) underwent elective surgery and 2 (6%), emer-
gency surgery. No postoperative deaths occurred. Of 29 patients com-
pleting telephone interviews, 24 (83%) had no or mild dysphagia; 21
(72%), no or mild regurgitation; 20 (69%), no or mild reflux; and 19
(66%), no or mild early satiety. Twenty-four (83%) patients had no or
minimal dietary restrictions; 26 (90%) had no or minimal social dietary
restrictions. Postoperative weight was not different from preoperative
weight. Of 30 patients, 26 (87%) felt better after esophagectomy and 25
(83%) would have the operation again. There were few predictors of
outcome. Younger patients were more likely to have dysphagia (P = .03).
Conclusions: Esophagectomy with gastric reconstruction relieves preop-
erative dysphasia and regurgitation in the majority of patients. Dietary
function and weight maintenance are excellent, attesting to the durabil-
ity of the procedure in patients with end-stage achalasia. (J Thorac
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GENERAL THORACIC SURGERY
ESOPHAGECTOMY WITH GASTRIC RECONSTRUCTION FOR ACHALASIA
of esophageal resection and gastric reconstruction for
end-stage achalasia.
Patients and methods
Protocol and variables. In 1988, a treatment protocol of
esophagectomy via the transhiatal route, gastric reconstruc-
tion, cervical anastomosis, and pyloromyotomy was adopted
as the treatment of choice, where possible, for benign end-
stage esophageal diseases. A prospective pathology registry
was used to record patients with benign esophageal disease
who had esophagectomy. It was used to identify and retrieve
for review the medical records of all patients with achalasia
undergoing esophagectomy with gastric reconstruction
through December 31, 1997. Preoperative variables, date and
details of esophagectomy, reconstruction, and postoperative
course were abstracted. Preoperative radiographic studies
including chest radiogram, barium esophagogram, and chest
computed tomographic scan were reviewed and maximum
diameter of the esophagus and width of the sigmoid segment
were measured.
Pathology review. The esophageal portion of the resection
specimens was evaluated and the following features were
recorded: (1) presence or absence of ganglion cells and the
number of ganglion cells; (2) presence or absence of myen-
teric neuritis, defined as inflammation within or immediately
around myenteric nerves, graded as mild, moderate, or
severe; and (3) presence or absence of myenteric neural fibro-
sis evaluated by the Masson trichrome stain, graded as mild,
moderate, or severe.1,2 In addition, the proximal esophageal
margin and the gastric cardia were evaluated, and the pres-
ence of ganglion cells was recorded.
Outcome. Weight measured at each postoperative visit was
obtained from medical records. Patients were contacted by
telephone and completed a questionnaire to define outcome
and gastrointestinal function. Symptom scores of 0 (absent),
1 (mild), 2 (moderate), 3 (severe), and 4 (incapacitating) were
used at the time of follow-up to assess abnormal gastroin-
testinal function as described by dysphagia, early satiety,
regurgitation, and acid reflux. Medications and procedures
required to treat these symptoms were recorded. Dietary
restrictions and the inability to eat at social events (social
dietary restrictions) were also scored from 0 to 4. Patients
were asked if they felt better after esophagectomy and
whether they would undergo esophagectomy again.
Complete symptom follow-up was obtained in all but 3
patients: 1 died, 1 refused to be interviewed, and 1 agreed to
a partial interview.
Statistical review. Symptom scores were obtained at only
one point in time for each patient. Ideally, these scores would
be ascertained at multiple points across time for each patient.
Because patients were treated over a 10-year period, we have
used longitudinal data analysis of these single assessments to
estimate the time-relatedness of symptom scores. This longi-
tudinal data analysis used logistic regression analysis, with
time interval since surgery used to assess temporal trends.
For each symptom, a sequential data analysis was done of
preoperative variables, pathologic findings, operative tech-
niques, and in-hospital complications. Preoperative variables
included gender, age at operation, symptoms, duration of
symptoms, dietary restrictions, prior therapy, complications
of achalasia or therapy, maximum diameter of the esophagus,
and maximum sigmoid width of the esophagus. Operative
variables included surgical approach (transhiatal or thoraco-
tomy), conversion of transhiatal approach to thoracotomy,
variations from the treatment protocol, and whether the oper-
ation was elective or urgent. Postoperative variables included
complications, need for blood transfusion, and intensive care
unit and hospital lengths of stay. Pathologic variables includ-
ed presence of ganglion cells, myenteric neuritis, eosinophils
and granulomatous inflammation in the resection specimen,
and presence of ganglion cells in the proximal esophagus and
gastric cardia.
Although the scores were expressed on an ordered scale,
few patients had symptom scores above 1. Thus scores were
dichotomized in two ways: 0 versus 1 to 4, and 0 and 1 ver-
sus 2, 3, and 4 for separate analysis. The two results were
consistent and, therefore, only the latter set is presented.
Because the data set is small, assessment of symptom status
used univariable statistics rather that multivariable statistics.
Odds ratios, 95% confidence intervals for the odds ratios, and
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Selected solids 6 19
No solids 9 28
Nothing by mouth 4 13
Prior therapy
Pneumatic dilation 25 79
Botox injection 2 6
Chronic self-dilation 1 3
Heller myotomy 16 50
Repeat myotomy 4 12
Fundoplication 3 9
Epiphrenic diverticulectomy 1 3
Gastrostomy or nasogastric feeding 2 6
Total parenteral nutrition 2 6
Preoperative complications
Weight loss (median 11 kg, 17 53
range 2-20 kg)
Aspiration pneumonia 7 22
Esophageal bleeding 3 9
Postoperative leak and abscess 3 9
Pneumatic dilation perforation 1 3
Respiratory failure 2 6
the P values were obtained from the logistic regression
model. McNemar’s test was used to determine whether symp-
tom frequency changed after surgery.
Unlike symptom scores that were available at only one
time for each patient, weight was measured before the opera-
tion and at each postoperative visit. A regression of weight
versus time after the operation was calculated for each
patient; slopes were obtained from the regression models.
The slopes were averaged, and a 1-sample t test was used to
determine whether the slopes differed significantly from 0.
This is equivalent to a longitudinal data analysis of repeated
measures. In addition, change in weight from preoperative to
follow-up was calculated. An analysis of variance model was
used to determine whether weight change was associated
with age at operation, gender, or length of follow-up.
Results
Patients and variables. Over a 10-year period, 32
patients with achalasia were treated by esophagectomy
with gastric reconstruction. During this time, 1 addi-
tional patient with end-stage achalasia and a previous
gastric resection had esophagectomy with colon inter-
position and is not included in this analysis. Seventeen
(53%) patients were women. Median age at operation
was 48 years (range 21-78 years). Before esophagecto-
my, symptoms were present for a median of 13 years
(range 1-44 years). Symptoms, diet, complications, and
treatment before esophagectomy are listed in Table I.
Median preoperative esophageal diameter was 6.2 cm
(range 3-10 cm) and median sigmoid width was 10.5
cm (range 3-17 cm) (Fig 1).
Thirty (94%) patients underwent elective surgery and
2 (6%) required emergency esophagectomy for uncon-
trolled esophageal bleeding. Transhiatal esophagecto-
my was possible in 21 (66%) patients and thoracotomy
was necessary in 11 (34%) patients. Five (16%)
patients had intraoperative conversion of a planned
transhiatal approach to thoracotomy because of dense
adhesions preventing transhiatal esophageal resection,
and 6 (19%) patients had resection by planned thoraco-
tomy. Cervical esophagogastrostomy was possible in
30 (94%) patients, but previous surgery limited the
amount of stomach available in 2 (6%) patients, which
made intrathoracic anastomosis necessary. The bed of
the esophagus was used for reconstruction in 31 (97%)
patients. In 1 (3%) patient who required emergency
esophagectomy, staged gastric reconstruction was per-
formed via a substernal route.
Median intensive care unit stay was 2 days (range 1-
12 days); median hospitalization was 14 days (range 8-
95 days). Seventeen patients required a median of 2
transfusions (range 1-12 units). Postoperative compli-
cations are listed in Table II. There were no postopera-
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Fig 1. A, Chest x-ray film shows a mass in the posterior mediastinum (arrows). B, Barium esophagogram con-
firms a very dilated sigmoid esophagus. C, Computed tomographic scan without oral contrast material again
demonstrates the dilated fluid-filled esophagus.
A B C




Temporary total parenteral nutrition 7 22
Aspiration 5 16
Anastomotic leak 4 13
Respiratory failure 3 9
Arrhythmia 3 9
Temporary vocal cord neuropraxia 2 6
Wound infection 2 6
Chylothorax 1 3
Note: Categories are not mutually exclusive.
tive deaths. One patient who underwent emergency
esophagectomy died 6 months after a complicated post-
operative course.
Pathology review. All resection specimens had
marked depletion of ganglion cells (Fig 2). In 20 (63%)
specimens, no ganglion cells were present. Severe
neural fibrosis was seen in all specimens. Severe neuri-
tis was identified in 17 (53%) specimens. The patho-
logic hallmarks of end-stage achalasia (ie, complete
absence of ganglion cells, severe neural fibrosis, and
minimal neuritis) were seen in 12 (38%) specimens. In
the proximal esophagus, ganglion cells were markedly
depleted in 28 (88%) patients, with no ganglion cells
present in 16 (50%). In the gastric cardia, ganglion
cells were absent in 9 of 29 (31%) specimens.
Outcome. At a median follow-up of 43 months
(range 3-115 months), all patients were able to eat
without intravenous or enteral nutritional supplementa-
tion. Postoperative weight (median 71 kg, range 46-104
kg) was similar to optimized preoperative weight (69
kg, range 48-120 kg) in both men and women (P = .2)
of any age (P = .9) and did not change significantly
with time (P = .2).
Symptom scores were available in 29 of 31 patients.
The assessment of symptom scores and postoperative
diet are listed in Table IIIa. With esophagectomy and
gastric reconstruction, dysphagia was reduced signifi-
cantly from 93% to 17% (P < .001) and regurgitation
from 90% to 28% (P < .001), with minimal change in
reflux from 24% to 31% (P = .5). Postoperatively, there
was a marked reduction of dietary restrictions from
59% to 17% (P < .001). Postoperative treatment neces-
sary to obtain these scores is shown in Table IIIb.
There were few correlates of outcome (Table IV).
Younger patients were more likely to have dysphagia
than older patients (6.1 times more likely to experience





Fig 2. A, Myenteric plexus from a control esophagus. The normal myenteric plexus shows easily identifiable gan-
glion cells (arrow) with essentially no inflammation. B, Myenteric plexus from a patient with achalasia showing
severe neuritis. There is a marked lymphocytic infiltrate with admixture of eosinophils and plasma cells. C,
Myenteric plexus from a patient with end-stage achalasia showing a scarred myenteric nerve. No ganglion cells
are identified and the degree of lymphocytic inflammation is minimal. D, Trichrome-stained section from the
same esophagectomy specimen as seen in C, showing a scarred nerve and minimal lymphocytic inflammation.
dysphagia for each 10-year decrease in age, P = .03).
Patients with a smaller sigmoid width were more like-
ly to have reflux (1.3 times more for each 1-cm
decrease, P = .06) and regurgitation (1.4 times more for
each 1-cm decrease, P = .07) than those with greater
width. Neither symptoms nor dietary restrictions
appeared to increase over time.
Among 30 patients, the condition of 26 (87%) was
improved after esophagectomy, the condition of 2 (7%)
was unchanged, and the condition of 2 (7%) was worse.
Twenty-five (83%) patients would undergo the operation
again, 4 (13%) were undecided, and 1 (3%) would not.
Discussion
End-stage achalasia. Achalasia is the result of T-
cell–mediated destruction and fibrous replacement of
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Table IIIa. Prevalence of symptoms and dietary restrictions at follow-up
Symptom score*
Symptom† 0 1 2 3 4 Total symptomatic (score >1)
Dysphagia
No. 24 0 1 4 0 5
%‡ 83 0 3 14 0 17
Regurgitation
No. 21 0 1 7 0 8
%‡ 72 0 3 24 0 28
Reflux
No. 18 2 1 8 0 9
%‡ 62 7 3 28 0 31
Early satiety
No. 16 3 7 3 0 10
%‡ 55 10 24 10 0 34
Diet
Dietary restrictions
No. 21 3 2 3 0 5
%‡ 72 10 7 10 0 17
Social restrictions
No. 20 6 2 1 0 3
%‡ 69 21 7 3 0 10
*Symptom score: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = incapacitating.
†These symptoms may have been achieved by medications, dilations (dysphagia), or gastric drainage (N = 4) (early satiety) as indicated by treatment in Table IIIb.
‡Percent of 29 patients with this symptom score.
Table IIIb. Treatment of symptoms
Symptom score*
Treatment† 0 1 2 3 4 Total treated
Dysphagia
No. 15 0 1 4 0 20
%‡ 63 0 100 100 0 69
Regurgitation
No. 0 0 1 4 0 5
%‡ 0 0 100 57 0 17
Reflux
No. 3 1 1 5 0 10
%‡ 17 50 100 63 0 34
Early satiety
No. 3 0 3 2 0 8
%‡ 19 0 43 67 0 28
*Symptom score: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = incapacitating.
†Treatment includes medications, dilations (dysphagia), or gastric drainage (N = 4) (early satiety).
‡Percent of patients with this symptom score requiring treatment (see Table IIIa).
the esophageal myenteric plexus.3 The inciting mecha-
nism of this inflammatory response is unknown.4 By
the time disruption of esophageal motility causes most
patients to seek medical treatment, substantial and irre-
versible damage to the esophageal myenteric plexus
has occurred. Many patients respond to pneumatic dila-
tion or myotomy of the lower esophageal sphincter.
However, no or delayed treatment, inadequate reduc-
tion of lower esophageal sphincter pressure, or peptic
stricture (the result of excessive reduction of lower
esophageal sphincter pressure and poor esophageal
clearance of refluxed gastric contents) may render the
esophagus amotile and obstructed.
End-stage achalasia may be characterized clinically,
radiographically, or pathologically. The majority of
patients have disabling dysphagia (including aphagia)
and regurgitation with associated weight loss and pro-
found dietary restrictions. Aggressive treatment and its
complications may further aggravate dysphagia caused
by the primary disorder. The radiographic findings in
end-stage achalasia are massive esophageal dilatation
and tortuosity (sigmoid esophagus) in the majority of
patients. Pathologically, there is a marked reduction or
absence of ganglion cells with fibrous replacement of
the myenteric plexus.
Treatment options in end-stage achalasia are limited,
and esophagectomy offers the potential for improved
swallowing. The principal function of the esophagus is
the rapid unidirectional transit of food from the
hypopharynx to the stomach. Unlike other segments of
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Fig 3. Colon interposition for end-stage achalasia. Massive dilatation and tortuosity developed in both the tho-
racic and abdominal portions of this colon interposition 3 years after esophageal replacement. There was return
of preoperative symptoms.
Table IV. Correlates of outcome
OR 95% CI P value
Preoperative
Dysphagia
Age (per 10-year 0.2 0.03-0.8 .03
increment)
Sigmoid width 1.4 0.97-2.0 .07
(per 1 cm decrease)
Regurgitation
Sigmoid width 1.4 0.99-1.8 .06
(per 1 cm decrease)
Reflux
Sigmoid width 1.3 0.99-1.8 .06




Anastomotic leak 7.3 0.7-73 .09
Pathology None
Assessment interval
Dysphagia (per year) 0.8 0.5-1.3 .4
Regurgitation (per year) 1.2 0.9-1.7 .3
Reflux (per year) 1.2 0.8-1.7 .3
Early satiety (per year) 0.9 0.7-1.3 .6
OR, Odds ratio; CI, confidence interval. 
the gastrointestinal tract, the esophagus has no diges-
tive, absorptive, metabolic, or endocrine activities.
Despite this seemingly rudimentary task and the decep-
tively simple arrangement of a muscle pump between
two sphincters, it is difficult to replicate esophageal
function.
Esophagectomy and colon interposition. Colon
interposition is a true esophageal replacement; it spans
the thoracic cavity to connect the cervical esophagus to
the stomach that remains below the diaphragm. In
expert hands, colon replacement offers restoration of
gastrointestinal function in patients with end-stage
achalasia.5 However, most surgeons have abandoned
colon interposition when the stomach is adequate for
reconstruction.6-10 There are many disadvantages to the
use of colon as an esophageal replacement,11 including
a propensity to late complications and a tendency for
the interposition to dilate and form redundant loops
(Fig 3).12-15 This late complication results in the same
problem for patients with end-stage achalasia that ini-
tially prompted esophageal resection. Reoperation for a
failed colon interposition was reported in 6 of 85 (7%)
patients undergoing esophagectomy with colon inter-
position for benign esophageal diseases.16
Esophagectomy and gastric reconstruction. The
treatment protocol of esophagectomy with gastric
reconstruction restored the ability to swallow in all
patients, with a marked reduction in the number of
patients with dietary restrictions. The improvement in
dysphasia and regurgitation apparently was stable over
time, and postoperative weight was stable and un-
changed from preoperative weight. These findings sug-
gest that gastric reconstruction is durable.
Dysphagia, the hallmark of end-stage achalasia and
the primary indication for most operations, was re-
lieved or minimized in the majority of patients.
However, patients who were younger reported more
persistent dysphagia than older ones. Patients with
achalasia have a disordered perception of swallowing.
Some of this reflects the disease process and some the
social aspects of eating. The fact that younger patients
were more likely to report dysphagia than older ones is
probably composed of multiple factors: shorter dura-
tion of disease, a memory of normal swallowing, social
activities that may foster dysphagia (such as active
lifestyles, eating fast food, eating rapidly), high expec-
tations of normal swallowing after gastric reconstruc-
tion, and more social situations in which eating and
drinking are focal points. A patient with an anastomot-
ic leak was more likely to have dysphagia.
A lesser sigmoid width was associated with an
increased chance of postoperative dysphagia, regurgi-
tation, and reflux. These unexplained findings were not
related to any variable or the pathologic findings in the
proximal esophagus or gastric cardia. However, this
observation suggests that esophagectomy for end-stage
achalasia should be considered only after alternative
treatment options have been exhausted and the esopha-
gus is dilated and has obtained a large sigmoid width.
With the advent of minimally invasive esophageal
surgery, laparoscopic Heller myotomy has been per-
formed generally without fundoplication in patients
without prior therapy or inadequate therapy regardless
of the sigmoid quality of the esophagus. Esophagec-
tomy with gastric reconstruction is reserved for
patients with documented failure of adequate myotomy
who have a sigmoid esophagus. This delay may avoid
esophagectomy in the younger patient and may
decrease the prevalence of dysphagia.
Conclusions
This study is limited by its being a single-institution
study of a small consecutive patient group with formal
assessment of outcome at only one point in time.
However, this work is strengthened by its protocol con-
struction. The use of gastric reconstruction for end-
stage achalasia is a procedure with low mortality and
morbidity commensurate with that expected for
esophagectomy. It relieves the preoperative problems
of dysphagia and regurgitation in the majority of
patients. There is good dietary function and, after pre-
operative restoration, weight is easily maintained.
These results appear to be durable. Delaying esopha-
gectomy until other treatment options have been
exhausted may improve outcome.
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Discussion
Dr. Tom R. DeMeester (Los Angeles, Calif). I enjoyed the
presentation by Dr Banbury. It was nicely done, well illus-
trated, and to the point. He has given us an opportunity to
review the long-term outcome of our therapy for the disease
achalasia. Those who have had 25 years of experience in the
management of this disease will attest that patients with acha-
lasia are charmed by anything that is done to improve their
ability to swallow. There are 2 reasons for this: First, even
though they often deny it, swallowing is so extremely difficult
for them that any improvement is often exaggerated; second,
eating makes up such a great part of our social lives that any
improvement is greatly appreciated. Consequently, it is diffi-
cult to know how successful the initial therapy of balloon
dilation or surgical myotomy is on symptomatic evaluation
alone. For this reason, about 10% will have progressive
esophageal dilatation over time and end up with what is
called end-stage achalasia. At this point, almost everyone
agrees, and the authors’ data certainly support, that esopha-
geal replacement is the only beneficial therapy. 
The focus of Dr Banbury’s presentation is that the stomach
makes a good esophageal substitute. This is a subject about
which I have given much thought, and I have the following
comments: First, swallowing after esophageal replacement
with either colon or stomach is never like swallowing with a
normal esophagus. Consequently, 17% of Dr Banbury’s
patients have persistent dysphagia, 25% regurgitation, 31%
reflux, and 44% early satiety. Yet 83% would elect to have the
operation again if that were possible. This tells you how
appreciative these patients are for any improvement in their
ability to swallow. My question is why 17% have persistent
dysphagia and why the younger patients seem to have more
difficulty. Can you explain this?
Dr Banbury. To answer your first question, the advisabili-
ty of positioning the stomach in the chest is a matter of
debate. Many of these patients with dysphagia are younger
but they do have the ability to swallow. Perhaps the anasto-
mosis, perhaps the denervated intrathoracic organ is the
cause. I cannot explain specifically why there is persistent
dysphasia in some, but certainly it is improved from the pre-
operative status. The use of prokinetic agents helps with
clearance of food and stasis. The specific reasons for dyspha-
gia are difficult to pinpoint.
Dr DeMeester. Did any of the patients with dysphagia
require dilation? 
Dr Banbury. Yes. We are aggressive in dilation. All of
these patients are monitored in the postoperative period with
endoscopy, and often they are treated by dilation during
endoscopy. Sixty percent of patients had postoperative dila-
tion with a median of 5 dilations per patient.
Dr DeMeester. Was the dilation mainly required because
of narrowing of their gastric esophageal anastomosis?
Dr Banbury. Any patient who had complaints with regard
to the anastomosis was subjected to endoscopy. We routinely
perform endoscopy in patients at a point in the postoperative
period. If there were problems with the anastomosis that we
identified on endoscopy, and in patients who had no com-
plaints, then we dilated the esophagus during endoscopy.
Dr DeMeester. In our experience the need for dilation after
a colon interposition is rare, less than 5% (J Thorac
Cardiovasc Surg 1998;115:1241). Thus there is an issue here
that I think needs to be evaluated in greater detail.
My second question deals with your emphasis on attention
to detail in regard to the operation. I appreciate that emphasis
and I think it is a very valid comment, particularly your
emphasizing the need to prevent redundancy of the stomach
in the thoracic cavity. Of course, the same admonition can be
applied to the colon; you must make every effort to avoid
redundancy of either substitute, colon or stomach. Could you
explain why preventing redundancy is so important in your
experience with the stomach?
Dr Banbury. There is concern about postoperative motor
function of the stomach, and redundant stomach could com-
plicate that situation. A straighter gastric tube allows gravity
to help the food bolus to pass straight through into the
abdominal cavity rather than to be hung up in folds in the
chest. That is also true with colon.
Dr DeMeester. Do you make any effort to tube the stom-
ach or reduce it in size, that is, to form a gastric tube as
opposed to the whole stomach?
Dr Banbury. The stomach is not specifically tubed, but the
proximal aspect is fashioned for the anastomosis.
Dr DeMeester. Do you anchor the stomach to the
diaphragm?
Dr Banbury. Yes, we do.
Dr DeMeester. My last question is in regard to an obser-
vation we have made, and I would like your thoughts about it.
In our experience it is very difficult to place gastric mucosa
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next to squamous mucosa without having a problem over the
long term. These problems start about 5 years after the oper-
ation. Studies have shown that a denervated stomach regains
its ability to produce acid similar to preoperative levels.
Because of this, 19% of patients will eventually have
esophagitis in the cervical esophagus on long-term follow-up,
and 12% will have Barrett’s esophagus in the cervical esoph-
agus, with the mean time for its development being 7 years.
This has not been associated with the use of the colon. My
question to you, Dr Banbury, is this: Have you had the oppor-
tunity to examine some of your long-term patients with an
endoscope? If so, what where the findings? I took note that
you have made some adjustments in your operation because
of concern over reflux, which suggests that the same thing is
happening in your patients.
Dr Banbury. We do routinely examine these patients with
an endoscope. We have not found esophagitis or endothelial
changes so far, but reflux is a problem in some of our
patients. We have changed our operative technique to try to
further reduce the complication of reflux. 
Dr DeMeester. Do the patients who have symptoms of
reflux have irritation of the throat or are they having aspiration?
Dr Banbury. Irritation. We do use acid suppression thera-
py in any patient who has this problem.
Dr DeMeester. That ends my questions. I do believe that
the best organ for long-term replacement of the esophagus is
still an open issue.
Dr John R. Benfield (Sacramento, Calif). Dr Banbury, this
is an important paper. My question is to you and perhaps to Dr
DeMeester as well. I would like to hear about the conventional
wisdom that you expressed, which is that the stomach remains
peristaltic whereas the colon is an aperistaltic conduit. Do you
actually have evidence that the stomach remains peristaltic?
Dr Banbury. No, we have not done studies of the stomach
to determine specific motility.
Dr Benfield. I doubt that the stomach remains peristaltic,
and I was wondering whether you had some evidence with
which to dispel my doubt.
Dr DeMeester. Our studies on the stomach show that it
does not regain peristaltic function; swallowing becomes
pretty much a gravity feed system. Our studies of the colon
show that it does provide some peristaltic function, but this
occurs several years after the operation. I commonly say to
the patients that the longer the colon is in the better it per-
forms, in contrast to the stomach. From my own experience
with these operations, about 5 years after a gastric pull-up the
patients start having trouble. I will be interested to see Dr
Banbury’s data as follow-up becomes longer. 
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